News Releases

For immediate release

CODEBASE VENTURES INC. UPDATES ITS WORLD HIGH LIFE INVESTMENT AS CAPACITY INCREASED FOR WHOLESALE BUSINESS

May 21, 2020 6:00 AM

LH BOTANICALS, WHOLESALE ARM OF LOVE HEMP, ADDS NEW TECHNOLOGY AND MANUFACTURING CAPABILITIES TO MEET GROWING DEMAND FOR NEW PRODUCTS

Read more

CODEBASE VENTURES INC. PROVIDES UPDATE ON ITS HYDROXYCHLOROQUINE INVESTMENT

May 20, 2020 12:05 AM

US National Institutes of Health Launches Phase IIB clinical trial to study Hydroxychloroquine and Azithromycin as a treatment for COVID-19 as US President Trump announces he is using Hydroxychloroquine

Read more

CODEBASE VENTURES INC. PROVIDES UPDATE ON WORLD HIGH LIFE INVESTMENT AS ITS WHOLLY OWNED SUBSIDIARY LOVE HEMP EXPANDS PRODUCT LINE IN UK

May 14, 2020 6:00 AM

Love Hemp Immune line accelerated to market to meet growing demand

Read more

CODEBASE VENTURES INC. INVESTMENT TRAD3R MOBILE GAME APP LAUNCHES BRAND NEW PLATFORM

May 13, 2020 6:00 AM

THE NEW TRAD3R APP IS BUILT TO TRADE 1,000S OF DIFFERENT CELEBRITIES, SPORTS TEAMS, STOCKS & FRIENDS

Read more

CODEBASE VENTURES INC. UPDATES ADVANCEMENT ON HYDROXYCHLOROQUINE STRATEGY

May 11, 2020 6:00 AM

COMPANY HAS SECURED RIGHTS TO INNOVATIVE TRANSDERMAL DELIVERY FOR HYDROXYCHLOROQUINE WHICH IS ANTICIPATED TO REDUCE SIDE EFFECTS AND IMPROVE OUTCOMES

Read more

CODEBASE INVESTMENT WORLD HIGH LIFE UPDATES SALES GROWTH OF WHOLLY OWNED SUBSIDIARY LOVE HEMP IN THE UK

May 08, 2020 6:00 AM

Love Hemp online sales increase by 39% month on month during global pandemic

Read more

CODEBASE VENTURES INC. ANNOUNCES SECOND CLOSING OF FINANCING

May 05, 2020 3:25 PM

CODEBASE INVESTMENT ADDS ORAL MUCOSAL PATENT FILING, EXPANDING TRANSDERMAL TREATMENTS

April 23, 2020 12:01 AM

New US Provisional Patent Filing for Novel Oral Drug Delivery of Chloroquine and/or Hydroxychloroquine Complements Transdermal Patch for drug used globally for Malaria, Lupus and Rheumatoid Arthritis

Read more

HYDROXYCHLOROQUINE SIDE EFFECTS POTENTIALLY MITIGATED BY TRANSDERMAL DELIVERY

April 21, 2020 12:05 AM

Codebase Investee has secured rights to develop a Transdermal Hydroxychloroquine Drug Delivery System to offer controlled, prescribed dosage mitigating side effects

Read more

HYDROXYCHLOROQUINE TREATMENT FOR COVID-19 BENEFITS SOUGHT IN GLOBAL RESEARCH EFFORT TO ESTABLISH EFFICACY

April 20, 2020 6:30 AM

Codebase investee has secured rights to Transdermal Hydroxychloroquine Drug Delivery System

Read more